cabozantinib,atezolizumab
roche
['contact-03', 'rcc,(-irccs),(-srcc),(-urcc)']
#asco23 live! rcc oral abstracts kicking it off contact-03 lba450 did not meet its primary endpoint pfs hr 1.03 and os hr 0.94 
Instructor of Medicine, Harvard Medical School. GU-oncologist at Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute. #conquercancer